NeuPath Ebitda from 2010 to 2024

Stocks . Canada . 
Stock . NeuPath Health
NPTH Stock  CAD 0.16  0.01  5.88%   
NeuPath Health EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA will likely drop to about -705.2 K in 2024. During the period from 2010 to 2024, NeuPath Health EBITDA regression line of quarterly data had mean square error of 160.7 B and geometric mean of  872,658. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-671.6 K
Current Value
-705.2 K
Quarterly Volatility
436.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NeuPath Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeuPath Health's main balance sheet or income statement drivers, such as Interest Expense of 949.3 K, Income Tax Expense of 234.3 K or Tax Provision of 258.3 K, as well as many indicators such as . NeuPath financial statements analysis is a perfect complement when working with NeuPath Health Valuation or Volatility modules.
  
This module can also supplement various NeuPath Health Technical models . Check out the analysis of NeuPath Health Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NeuPath Stock Analysis

When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY